National Lab Briefs

A recent National Academy of Sciences study of five research reactors at the Department of Energy’s national laboratories left out far more than it actually said. The report, released in August, criticized DOE’s ‘fragmented” oversight of the reactors and concluded that aging and brittle components could be safety hazards. But the published criticisms were muted compared to what the academy told reactor officials in private. In informal sessions held before the report was

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A recent National Academy of Sciences study of five research reactors at the Department of Energy’s national laboratories left out far more than it actually said. The report, released in August, criticized DOE’s ‘fragmented” oversight of the reactors and concluded that aging and brittle components could be safety hazards. But the published criticisms were muted compared to what the academy told reactor officials in private. In informal sessions held before the report was released, NAS scientists described a long and detailed list of problems that threatened the safety of the reactors. The detailed criticism was omitted from the report “to avoid redundancy,” says NAS panel chairman Richard Meserve.

The report was not the first time the academy had used this tactic. Last year, another NAS panel told DOE informally about serious safety hazards in government reactors that produce materials for nuclear weapons, and DOE immediately cut by more than half ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies